Regeneron Pharmaceuticals, Inc. (REGN)
NGS · Common · CUSIP 75886F107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for REGN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
75886F107
Market Cap
Large Cap
Business: Regeneron Pharmaceuticals, Inc. is a leading science based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases.

Company Contact

CEO
Dr. Leonard S. Schleifer, M.D., PhD
CFO
Chris Fenimore
Headquarters
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707
Phone
914-847-7000
Investor Relations
Mark Hudson · 914-847-3482 · Mark.Hudson@regeneron.com
General Email
invest@regeneron.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »